Informed Consent and Aphasia: Bioethical Challenges Explained

Introduction: Informed Consent and Aphasia

Informed consent constitutes a legal and moral requisite for any research involving human beings. Study subjects are provided information regarding every element of a clinical trial deemed vital for their decision-making, including the study's significance for societal welfare and for advancing the medical field. After examining every trial-related facet, subjects ought to be able to voluntarily confirm their readiness to participate in the given clinical trial. This informed consent principle is embedded in the Helsinki Declaration, the Belmont Report, and the Nuremberg Code. It is compulsory before commencing any study that entails human research subjects (Jayes & Palmer, 2014).

This provision essentially addresses whether a subject's mental or physical state allows for informed, well-considered decision-making. Aphasic individuals, however, are not always able to satisfy the aforementioned informed consent requirements, giving rise to moral and ethical challenges such as communication problems, erroneous decisions, surrogate consent usage, conflicting doctor-researcher interests, and recruitment timing difficulties. A thorough analysis of two key bioethical concepts — the need for a detailed discussion of a study's advantages and risks, and respect for subject autonomy — reveals their significance in the matter of informed participant consent.

The Ethical Dilemma and Its Impact on Nursing

Ethical problems surface for aphasic individuals, especially those with severe aphasia, resulting in their frequent exclusion from research participation. Even studies that expressly aim to examine stroke survivors' experiences often exclude this patient population. Consequently, there is limited scope for generalizing research findings to aphasic stroke patients. Moreover, this practice denies aphasics the right to participate in research. Even in studies intending to include aphasics, the challenges of obtaining their informed consent underscore their vulnerability during recruitment (Jayes & Palmer, 2014).

Diminished communication abilities can obscure a person's capacity to engage in informed decision-making. This impacts the field of nursing because researchers with a limited understanding of aphasia may mistakenly conclude that individuals with impaired speech or language expression lack the capability to provide informed consent. Conversely, misjudging a person's comprehension abilities may lead researchers to assume incorrectly that the individual can offer well-considered consent. As a result, aphasic individuals may be enrolled in research without fully understanding the major implications of participation, potentially exposing them to upsetting or harmful experiences (Jayes & Palmer, 2014).

Ethical considerations represent a key concern in designing and conducting clinical studies. Numerous completed stroke therapy trials give rise to challenging ethical dilemmas. Issues may arise when the treating physician is also the researcher or a research team member. In such scenarios, severely ill individuals or their family members may not always be able to differentiate between standard therapies, toxicity studies, and therapeutic trials, and they will often simply follow their doctor's advice. A treating physician's responsibility is, of course, to promote and safeguard their patients' welfare. However, when serving a dual doctor-researcher role, that responsibility may conflict with research goals. The possibility of such conflicts has led a number of commentators to recommend a clear separation between the treatment team's role and the researcher's role (Slyter, 1998).

Core Moral Issues in Aphasic Research Participation

The ability to use language for oral or written communication requires both the ability to understand information and the ability to convey it to others in an understandable way. A large number of rehabilitation patients may suffer from diverse types and degrees of aphasia. Where language deficiencies affect comprehension, obtaining informed consent for research will be inherently difficult, and researchers may be forced to either exclude these individuals or seek proxy consent. Patients with expressive deficiencies may be able to offer non-verbal consent; however, participating in a study protocol may prove difficult if researchers do not incorporate specific mechanisms to accommodate their communication needs (Blackmer, 2003).

Under circumstances where prospective participants are believed to have aphasia, an exhaustive assessment should be conducted to ensure the patient can provide consent for participation and possesses adequate communication skills for actual study participation. Additionally, the services of speech-language pathologists may facilitate participation for individuals whose communication difficulties would otherwise prevent their inclusion (Blackmer, 2003).

Many hospitalized rehabilitation medicine patients are individuals who have experienced critical, and at times life-changing, medical conditions or injuries. Given sufficient time to adapt to their changed circumstances, some of these individuals may eventually adopt a different perspective and willingly volunteer for studies following physical and mental recovery. However, many research designs require participant assessments throughout the course of hospitalization for rehabilitation, with some continuing after discharge. Thus, recruitment may be necessary at an early stage — before comprehensive behavioral and cognitive evaluations have been completed — meaning that patient recruitment may be required before researchers can fully clarify the individual's ability to provide informed consent (Blackmer, 2003).

The informed consent requirement presupposes that a subject's mental or physical state allows for informed, well-considered decision-making. When aphasic individuals cannot satisfy these requirements, researchers may be prompted to seek surrogate third-party consent. Healthcare team members will frequently be pressed to seek surrogate consent for aphasic patients or for individuals with sensorimotor deficits or altered consciousness that impairs their ability to write. This is, however, a relatively indirect procedure in other scenarios — such as anosognosia, neglect, visual field loss, or moderate comprehension difficulties — where consent is not entirely "informed" (Mendyk et al., 2015).

Two Bioethical Principles Applied to the Dilemma

One central requirement of research ethics codes is that the significance of a study's goals is proportionate to the risks borne by research subjects. A clinical trial may offer direct benefits to certain participants — for example, the chance of receiving a newly developed, highly effective drug not yet licensed for general use. Without clinical equipoise, however, a clinical trial would not be ethically justified: if researchers definitively knew that a given medication was superior to all other interventions, withholding it from a control group would be unwarranted. Participants are asked to share in a study's uncertainties — they may experience benefits, but they may also be assigned to the control group, or the experimental drug may produce harmful side effects or prove less effective than existing treatments. In short, researchers can rarely promise participants direct personal advantages. Nevertheless, studies ought to be either directly beneficial to participants or to the broader community, and research benefits should appreciably outweigh the likely harm to subjects (Slowther, Boynton & Shaw, 2006).

Respect for participant independence and integrity lies at the core of the informed consent principle. A major function of ethical review is to ensure that consent to study participation is properly obtained and recorded. The consent process should take into account prospective subjects' cultural values in order to genuinely honor their autonomy. Legitimate consent for any medical procedure — clinical or research — requires: (a) informing the individual of the nature of the procedure, including its potential benefits and risks; (b) the individual's ability to engage in decision-making; and (c) voluntary, uncoerced decision-making. Each of these elements must be considered within the precise context of the proposed study and is guided by the principle of respect for autonomy (Slowther, Boynton & Shaw, 2006).

Study subjects cannot make autonomous decisions about whether to participate if they lack relevant information. As in clinical practice, clinical research ethics involves two key factors in ensuring truly informed consent: (1) the content of information — its accuracy, detail, and clarity; and (2) the process by which information is communicated — its context, the time allowed for reflection and discussion, and the power balance between researchers and participants. Furthermore, voluntary and valid consent must be freely given. Research ethics committees and investigators must consider whether the consent process involves any direct or indirect coercion of participants (Slowther, Boynton & Shaw, 2006).

Conclusion

Respect for the autonomy of study participants and the need to comprehensively discuss a clinical intervention's advantages and risks are two highly important aspects of the informed consent process. For aphasia patients in particular, unique challenges arise in balancing these ethical requirements. While individuals with aphasia generally retain their decision-making capacity, their ability to fully participate in a conversation about a potential clinical intervention is often impaired. It is therefore recommended that researchers enhance their informed consent acquisition processes for aphasic participants while also expanding and protecting participant autonomy and decision-making engagement. Employing patient-chosen "helpers" in this process may improve the quality of informed consent while preserving the individual's ultimate decision-making authority (Stein & Brady Wagner, 2006).

References

Blackmer, J. (2003). The unique ethical challenges of conducting research in the rehabilitation medicine population. BMC Medical Ethics, 4(1), 2.

Jayes, M., & Palmer, R. (2014). Initial evaluation of the Consent Support Tool: A structured procedure to facilitate the inclusion and engagement of people with aphasia in the informed consent process. International Journal of Speech-Language Pathology, 16(2), 159–168.

Mendyk, A. M., Labreuche, J., Henon, H., Girot, M., Cordonnier, C., Duhamel, A., . . . & Bordet, R. (2015). Which factors influence the resort to surrogate consent in stroke trials, and what are the patient outcomes in this context? BMC Medical Ethics, 16(1), 26.

Purtilo, R. B., & Doherty, R. F. (2016). Ethical dimensions in the health professions.

Slowther, A., Boynton, P., & Shaw, S. (2006). Research governance: Ethical issues. Journal of the Royal Society of Medicine, 99(2), 65–72.

Slyter, H. (1998). Ethical challenges in stroke research. Stroke, 29(8), 1725–1729.

Stein, J., & Brady Wagner, L. C. (2006). Is informed consent a "yes or no" response? Enhancing the shared decision-making process for persons with aphasia. Topics in Stroke Rehabilitation, 13(4), 42–46.